US 8394387
Recombinant modified Bacillus anthracis protective antigen for use in vaccines
granted A61KA61K2039/505A61K2039/53
Quick answer
US patent 8394387 (Recombinant modified Bacillus anthracis protective antigen for use in vaccines) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Mar 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61K2039/53, A61K39/00, A61P